Project Details
Description
This study will assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.
| Acronym | VALUE |
|---|---|
| Status | Finished |
| Effective start/end date | 1/07/19 → 30/08/25 |
Collaborative partners
- AbbVie (lead)
- Abu Dhabi Health Services Company
Keywords
- Chronic Plaque Psoriasis Risankizumab Biologics Psoriasis
- Vulgaris
- Skin Diseases
- Papulosquamous
- Psoriasis
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.